In this episode we go beyond just cannabis & CBD genetics. A small Israeli based startup, BetterSeeds, is on a mission to create better seeds for all the crops grown worldwide. Better crop genetics will be the key solving the growing demand for increased production.
BetterSeeds makes use of genome editing technology (CRISPR-Cas9) in order to produce new varieties, incorporating game changing traits which are not today available across all crops due to the limitations of conventional breeding. One example of this is ketchup. Without one genetic trait that was discovered in tomatoes a few decades ago we wouldn’t have had ketchup.
We interviewed BetterSeeds CEO/Co-founder, Ido Margalit, who helps explain the science behind BetterSeeds. And Ido helps to explain how their technology is also improving the Cannabis & Hemp industry. Listen to our latest episode.
Connect with BetterSeeds:
https://www.betterseeds.com/#Hero
https://www.linkedin.com/company/betterseeds-ltd/
Please subscribe to be notified of the next episode release - Like & Share!
You can reach out to us for all of your Cannabis PR solutions. Check out our website for more details.
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Ronjini Joshua (00:11):
Hi, this is Ronjini Joshua, I'm the host of
the green room podcast. Thislast week we were at mjbizcon.
And we met some amazing guestsand heard about some really cool
brands that are innovating thecannabis industry and and what's
coming next in the new year.
Hello, today we're here with IdoMargalit, the CEO of can breed.
Thank you for joining us on thepodcast. Thank you.
Ido Margalit (00:35):
Glad to be here.
Ronjini Joshua (00:36):
Yeah. And so we're here for mjbizcon. This
week, and what is the mostexciting thing to you about
what's going on this week?
Ido Margalit (00:44):
Well, I would say that this is the first
conference in cannabis thatwe're participating in
specifically also in the UnitedStates. Okay. I think the most
amazing thing is the sheer sizeof this conference, the amount
of people I mean, coming fromIsrael and also seeing the
European operations This isdoesn't come anywhere close to
that.
Ronjini Joshua (01:03):
Yes. Is this your first time you're, you're
exhibiting this year we areexpanding? And is this your
first time at mjbizcon? Or asyour first time exhibiting both
both? Okay. Okay. Okay, cool. SoI would love to hear a little
bit more about yourself and yourbusiness and can breed and what
you guys are doing at the showwhat you expect out of it and
some exciting things that youexpect to come out of cannabis
(01:26):
in 2022.
Ido Margalit (01:28):
Yeah, I'd be very happy to tell you everything.
Yeah. So maybe a little bitabout myself, please. So I'm an
agronomic by my education andalso have a master's in
business. I have 23 years ofexperience in Israeli life
sciences sector, great workingfor pharmaceutical companies for
agricultural companies.
Actually, the previous positionthat I held before founding this
company was being the BusinessDevelopment Manager for
(01:51):
Syngenta. Syngenta is theEuropean Monsanto, okay? And at
their seeds division, whichwould lead to the reason why we
founded Cambria. Okay. And aboutfive years ago, both me and also
the other co founder Dr. TangChairman we he was a scientist
also at the seeds division inSyngenta, we decided that we
want to create our own seeds andgenetics company that uses these
(02:15):
really innovative andbreakthrough technology called
CRISPR. I don't know if youheard about this technology. It
just won by the way, the 2020chemistry Nobel Prize, oh wow,
this is gonna revolutionizemedicine, agriculture as we know
it. So we're already eight yearsago, we became a acknowledge
with this technology. And wesaid, Okay, we're going to form
our own genetics and seeds,company, and we wanted to do new
(02:37):
things and develop betteragricultural crops. But there
was no money. Nobody understoodCRISPR means here, after almost
a decade after developing it,few people know about this
technology. So investors knewnothing. And it was that we want
to do CRISPR on tomatoes. And soI said, well, so that
interesting, there was no money.
(02:58):
And then we looked at cannabis.
Now immediately, as seeds,industry people, we understood
the two biggest gaps that existin cannabis. And we said there,
we can solve it. And the twobiggest gaps is one, it's very
expensive to grow, because thegenetics do not fit mass scale
production. And the otherproblem is there's no
standardization, there's nouniformity and consistency. So
the two solutions are stableseeds and enhancing those seeds
(03:20):
with agronomic traits that willenable very efficient and and
very high quality material.
Ronjini Joshua (03:30):
Yeah, so I think what I'm hearing a lot this
year, and just seeing mjbizconis a lot of people are focusing
on the seeds, because that'skind of the future of cannabis
is how are we going to scale theproduction of cannabis? And how
are you going to get the sameplants in different places? And
and and all that. So how is thatincorporated into your business?
(03:52):
And, you know, what are youlooking at as the trends of what
you're doing with CRISPR.
Ido Margalit (03:57):
So I think the biggest solution and the most
game changing solution isactually bringing those seats
when you do not need to do anymore cloning, no more clones,
once you have the stable seats,no more tissue culture cloning,
no more mother vegetative fromother plants, cloning, normal
cloning, you buy a bag of seeds,10,000 seeds, 100,000 seeds, 1
million seeds, and you put allof them in the in the greenhouse
(04:20):
and you get the identicalplants. So it saves time, it
saves labor. And after that youget the consistency and the
uniformity. This is the biggestbiggest solution. But as I said,
it's not enough because stillthere's a lot of problems. I
mean agricultural crop, you havea lot of hardships, you have
Diseases Attacking it, you haveto adapt the structure of the
cannabis plant mean, the soy andthe tomatoes we consume today.
(04:42):
We're actually domesticated fordecades, if not for centuries to
fit, intensive agricultureoutputs and halibuts was not so
only using CRISPR. Can youactually domesticate the
cannabis plant and fit it intointensive agricultural farms
within a very short time? Wedon't have the two three decades
wait for conventional breedingto get to that we need to do
(05:04):
that within the next five years,and only CRISPR can do that
solution. Wow.
Ronjini Joshua (05:09):
So what do you see as the biggest opportunity
with that then, obviously, massscale production, but coming
from Israel and coming into theUS market, how are you guys kind
of working through thechallenges of the US market.
Ido Margalit (05:24):
So I think that we sold one big challenge very
easily because we are both inthe hemp and also in the, in the
medical and recreationalsegment. So the medical
recreational segment, we soldthe situation in the US very
simple. We're not in there.
Until you solve it federally,we're not touching any kind of
base in the in the medical andrecreational so that we're only
(05:45):
focused on the hemp side in theUnited States. And I think that
as I said, we should we bringthis uniform seats when you buy
1 million seeds from us is goingto be identical consistency and
standardization. But then thegrowth here face a lot of other
problems they face also the highTHC. So with crisper, you can
have no THC, THC free plants.
(06:05):
There's another downside togrowing hemp because it's an
outdoor production mainly, atleast if you want to have your
production costs go really down,you can't do it in the
greenhouse, then you have aweeds that the take over the
growth and they you have 10 to15% loss of duty weeds. So we
have a herbicide resistant hemp,and also disease resistant, etc,
(06:26):
etc, we have these economicaltrade platform that solves
basically, I would say most ofthe challenges of growing hemp
in the United States. So you cando effectively with high
quality.
Ronjini Joshua (06:36):
So tell us a little bit about your team
because it sounds like you havea very scientific focus team. So
tell us a little bit about howit what you guys are doing as
far as the research and thedevelopment within the company.
Ido Margalit (06:48):
I would say that we are much more a biotech
company, an agriculture company.
So we have over 20 Scientistsworking at the company. Most of
them are molecular biologists.
It's a fancy name forgeneticists. So what we
basically do we look at thedifferent challenges that the
growers face, we'll look at thetraits that will solve those
(07:09):
different challenges. Ourscientists look at the genes
that once you edit them, you getthose traits and then we design
the CRISPR that will actuallyedit the gene to get the
positive trade out of theplants. So this is what we do.
So we are basically a geneticbiotech company that's focused
mainly in cannabis at this pointof time. By the way, we're not
only doing cannabis, but westarted cannabis. We're focused
(07:31):
on cannabis. We're doing manyother crops as well.
Ronjini Joshua (07:34):
Okay, so your group crop scientists, yeah. All
crops. Okay. Land scientists,plant scientists, though. Okay.
Well, but so what you do withCRISPR can apply to any kind of
plant or agriculture.
Ido Margalit (07:45):
It does. And it's exactly what we do. We're also
in soy, we're also in tomatoes,where most of the cash crops for
agriculture, but we began incannabis, our journey as I said,
our journey actually begancannabis because there was money
in cannabis. Right. But now,everybody well, at least in my
in my segment, now people knowthat CRISPR and people
(08:05):
acknowledge the fact that allagricultural crops need to be
enhanced, and only CRISPR willbring the solution for the for
the for the future ofagriculture, and feed the world.
So now it's much easier for usto get the money to do other
crops as well.
Ronjini Joshua (08:18):
What kind of companies do you guys partner
with? Well, we
Ido Margalit (08:22):
partner both with multinational seeds, companies,
we partner also with a couple ofcannabis companies. And of
course, we partner with a lot ofresearch institutes. But but as
I said, since we're not onlycannabis when we partner with
those guys, it's not just forcannabis. It's for a lot of
other things. But we are lookingvery actively to partner with
young plant nurseries, seedlingnurseries, and also for
(08:44):
cannabis. Because we see theevolution of the cannabis
industry. So you have the plantand the seeds business. The next
in the in the supply chain areactually the nurseries. Yeah,
because in agriculture, thefarmers, let's say vegetables,
which is a high value croproaming greenhouses, just like
canavese the farmers they don'tbuy the seeds from the seed
(09:05):
companies they buy young plantplanners. Yeah, actually our
customers are not growsthemselves. They are the plant
nurseries. So we've come here toactually look for customers
because we're starting to sellin 2022. So we're talking to the
farmers and to the growers,because they're much more than
that than they are in nurseries,but we're also looking for the
(09:26):
nursery.
Ronjini Joshua (09:26):
Do you imagine that you know in the future when
it is legal here in the UnitedStates and wherever else it's
going to be legal. Do youimagine there'll be cannabis
nurseries
Ido Margalit (09:35):
of course yeah, in Israel, there's already starting
to be a young plant nurseriesfor cannabis. Okay, there's very
few in the United States andit's very few in Canada, but at
least I can tell you what theytold us in Israel. So there's
young plant nurseries that arenot doing cannabis, but they
have the know how and theresources to add cannabis and
they said, We're waiting forstable seats. There's no reason
for us to do any germination ofseason to end to sell young
(09:58):
planetaries if there's no stableseats, Now you've come now we
are entering also the cannabisindustry.
Ronjini Joshua (10:03):
So that is a challenge I've heard of and
don't obvious I'm not a farmeror grower. So I don't know much
about it. But is that a bigissue for the cannabis industry
where they're, you know, growingcertain plants, but not all of
them are producing what theyneed? Is it? What is the what is
the loss amount when you do acrop? Typically,
Ido Margalit (10:25):
what exactly do you mean from the amount of the
cannabinoids,
Ronjini Joshua (10:28):
you mentioned it? Yeah, you were mentioning
that like, you know, thegermination doesn't kind of
fully, fully mature. So do allthe seeds because the seeds are
not the same? Or because they'renot uniform? Are you seeing a
lot of drop off of plants thatthey can't people can't use?
Ido Margalit (10:46):
Well, in our products or from the other
products in the industry. So Ithink we met already potential
clients in the in the days thatwe've come before the
conference. And they said, Youguys have a lot of challenges.
You don't need to market educatethe people that you must need
seeds to replace cloning, you'reactually challenge is all the
previous companies that came andsaid that they're doing exactly
(11:08):
what you're doing. And theydidn't have it. So they had low
germination rates, they do nothave the consistency, the
stability and the uniformity. Sothe challenge is that proving
that we're not doing the same BSas the other guys before us.
That is the biggest challenge.
And we're not basing we actuallyhave 1%, stable genetics, we're
actually bringing the practicesof the conventional seeds
business. This is the first timewe've broken all the glass
(11:29):
ceilings that in the pastdecades existed in this
industry. And I hope that ourpotential customers will trust
us and understand that we're notdoing the BS that the guys
before us have done.
Ronjini Joshua (11:45):
So you guys are coming from Israel. Can you tell
me a little bit more about yourlike kind of how you guys got
started? How did cambrie getstarted in the first place?
Ido Margalit (11:52):
So as I mentioned, a US being for the seeds
industry. And it was very easyfor us to actually understand
those gaps. Okay, so weimmediately understood any
agricultural crop, and cannabisis just another crop crop. By
default, you have to grow itfrom seed doing a propagation
from vegetative propagation. Youonly do that if the plant does
(12:13):
not know how to propagate itselffrom seeds. So bananas,
strawberries, even potatoesuntil recently, you did
vegetative cloning, vegetativereproduction of it. And can I
be, well, everybody knows theseeds, it doesn't have to
produce itself. But it's notenough just to use the seed as
nature has done it because it'snot stable. When you take a seat
(12:33):
for one plant or the day you get100 seeds for one plant, all
those 100 seeds are geneticallydifferent from each other. You
need to invest a lot of science.
That's why we're we're alreadyalmost five years existing. And
people have asked me already inthe conference today. So what is
your revenue? And I say, I mightsay even one very proudly, one
big fat zero, because five yearshuge amounts of investment. This
(12:55):
is science. It takes a longtime. And if people believe Oh
yeah, I'm gonna do the same, youknow, within two or three
cycles, six to eight months aregoing to have the same thing as
you had, and I'm going to sellit. No, it takes five years to
get to the point that we arethat is why we actually do have
the stable genetics. Yeah. Andthis is the route that we did.
We come from the conventionalseeds business, we're taking the
(13:18):
practices, and for the firsttime we're inputting them into
cannabis, and I think is thefirst stepping stone of the
cannabis industry to mature andbecome a standard diseased
industry.
Ronjini Joshua (13:30):
Yeah, and that's another problem that, you know,
another problem people arefacing is standardization and,
and getting quality productsthat are streamlined, you know,
I think this kind of seedgenetics probably really helps
mass produce this at a scalablekind of rate.
Ido Margalit (13:46):
Exactly. Yeah.
That is a joke in Hebrew that Ican translate, I believe to
English, but it's like this, thecannabis industry over the world
is like building a penthouse ona high rise building, but
building it from the top down,right, okay. And there's no
foundation and the foundationthis business is genetics. So if
there's no stable genetics, youwill never have this
standardization, you will neverbe able to go and buy at the
(14:06):
store the same time you receiveda very good vibe, a very good
feeling. You enjoy the productand you go again, I mean, when I
buy a Coke, I expect my coke inIsrael in the US in England,
wherever to be the same. Youcan't get that and Canalis only
when you get to the stablegenetics like we have will you
get to that point for bothrecreational and of course
medical, you will get the sametype of reproducibility and
(14:27):
standardization.
Ben Michaels (14:30):
Have you found that you've been able to you
know, because like there's thestrands that are very popular
and across the board and thenthere's like more of the
boutique brands that are reallytrying to get complex you know,
terpenes and high THC when youare these seeds you know that
you're making right now are youtrying to accomplish all of that
you're trying to get high THCand complex terpenes with with
(14:53):
that stability, are you findingthat you have to sacrifice one
or the other for thatconsistency.
Ido Margalit (14:59):
We can look cover the entire spectrum of the
market, it's impossible, as ourstrategy is to have a few dozen
varieties that we select Appleaccording to two criteria. I
mean, you have people heregrowing the same variety in the
winter, in the summer in theautumn growing in Washington
growing in California, itdoesn't matter that agricultural
crops, you have to have aspecific variety for specific
(15:20):
season in a specific spot. Soalready by default, we
understand that using just onevariety, it doesn't fit. It
doesn't
Ronjini Joshua (15:27):
work like that, like fruits and vegetables.
They're exactly there duringcertain times of the year.
Exactly.
Ido Margalit (15:31):
So we we are, we're going to have a product
profile of a few dozen varietiesthat are going to be selected
according to plant performance.
This grows well in the winter,this grows well in the summer,
okay. And from those that fitthe summer, winter, wherever
indoor outdoor that we have alsoselection according to the
contaminant concentration, thisis high THC, low CBD high CBD
(15:51):
this is even, et cetera, etcetera. So we will have a
catalog that hopefully coversthis spectrum, will it fit?
Specifically I want thisspecific Can I get a
cannabinoid? Nothing CBD or THC,whatever, or this specific
terpene? Maybe not. But if youwant the uniformity and the
standardization, and you'rewilling to let go of that
specific teeny, weeny littlething, then I'm your guy.
Ronjini Joshua (16:16):
Yeah, I think I think maybe not so much for the
boutiques, but for the MSOs thatare going to be doing national
production of big, big brandsthat are going to be doing that
they're going to be looking for,you know, your kind of solution.
But there's, that's, that's kindof how the market is today,
right? You've got boutiquepeople like let's, you know,
we've been talking a lot aboutthe comparisons between wine and
beer, and you've got the craftwine, and then you've got or the
(16:39):
craft beer, and then you've gotlike the large, you know, mass
produced, like big brands thatpeople like. So I think that
kind of translates
Ido Margalit (16:49):
complete with you.
And I like always to bring ametaphor from the conventional
agriculture business. Yeah. Sofrom our business, we have the
organics guys, right, right.
It's a niche market. So they'reabout three to 4%, the total
market so they won't buy theconventional seeds. They want to
own organic seeds from their ownorganic varieties. So they won't
go to the Monsanto to thepioneers of those large,
(17:11):
multinational companies. So Icater the 95 96% of the market.
So the four or 5% niche to take.
So probably I can give asolution to them. Maybe they
wanted to invest and to pay meto develop their genetics, they
will be fit for growing fromstable seeds. Maybe that's
assumption solution. But I aimfor the 95% of the market, right
(17:31):
for the nation, boutique market.
Ronjini Joshua (17:34):
Yeah. Well, I mean, there has to be a little
bit of everything, right? No,absolutely. There will be. Yeah,
a little bit of everythingavailable. That's exciting. I
mean, it's really interesting tosee it be the industry be at the
stage and time and we're meetinga lot of people that are really
just getting into the groundfloor of what's happening with
cannabis and how it's going tobe blowing up in the next few
(17:58):
years. As, especially here as itbecomes legalized, it's going to
be kind of like a, it's going tobe something to look at, you
know, something to watch andsee. What are you most excited
about? I mean, you have a lot ofreally cool technology behind
what you're doing. What are youmost excited about?
Ido Margalit (18:14):
I would say I'm most excited about being the
groundbreaking company. Yeah, Ihave to say that. I mean, that
we've faced so many backlashesof the past five years, people
have been telling us and I stillreceive emails for massive
growth in the United Statessaying that you cannot get to
stable seats. you'rebullshitting and this is
something possible. This is soI'm so I'm breaking as I said,
(18:37):
glass ceilings, I'm changingconcepts. And also being the
first company to actually takingthis CRISPR technology and being
able to apply it in cannabiswhere so many other people have
failed. You have these largegrowers, a companies in Canada,
they failed, you know, thecanopy that Tiller that they
failed, and me as a smallIsraeli company, like like a
(18:59):
small commander unit, withlimited resources of limited
people were actually managed tosolve all those problems that
bigger, stronger and moreveteran people in in the
cannabis industry than us theycouldn't solve it. This is what
I'm really most excited about.
Ben Michaels (19:16):
So not to take a step back from what you were
excited about, but I find itvery interesting that you're
mainly the big focus right nowis the hemp and hemp market. So
I'm just curious so like it'ssome of the things like trying
to get you know, no THC with themost amount of CBD or literally
(19:37):
strengthening you know, the cellwalls of the plant, you know, so
it's, you know, whatever thathemp depending on what that hemp
is going to be used for. Do youhave some of that same variety
with you know, him specificCRISPR technology.
Ido Margalit (19:50):
So this is exactly what we're doing. And by the
way, using this gene editingthis CRISPR technology, I would
say the sky's the limit in inregard to what you can do to the
canavese planet hemp plantwellness exam is probably for me
hemp is also cannabis, ofcourse, it's the sky's the limit
that anything is possible fromplaying with all the different
cannabinoids from, as you said,changing the plant architecture,
(20:11):
I can tell you that one of theof the traits that we're working
on, not only does it make theplant autoflowering and by the
way autoflowering, we're notusing a ruderalis, you can play
with a gene that actually turnsoff and on the plant need to
look at the amount of daylightso you don't get the genetic
drift or with violence or thecrapping and people cross
(20:32):
Hamburg valleys, you get a lotof crap from from ruderalis in
this instance, you take the hempplant itself and you edit the
gene, there's no anything thatcomes from the root of it. So
you get a very good, very strongvery vigorous hemp plant. And
not only that this specific genealso makes the flowers appear
almost simultaneously. Soinstead of having you can say
like floors, then all theflowers more or less appeared
(20:53):
some fancy which makes it muchmore fitting for mechanical
harvesting. Oh
Ben Michaels (20:57):
wow.
Ido Margalit (20:58):
So you reduce the time you make the flowers appear
simultaneously and you can thenmechanically harvested like in
cotton like in soy like in allthe other our culture open field
crops.
Ben Michaels (21:08):
Yeah, no, that's such a such a pain and
especially for the ones that doit by hand and having everybody
do it because it's, you know,the the flowers growing
everywhere in differentdirections. There's no way to
streamline it. That'sincredible.
Ronjini Joshua (21:18):
Yeah. Do you think that, um, you know, this
kind of cannabis revolution? Doyou think it's opening up
opportunities for agriculturalinnovation, just in general that
like, cuz I, I mean, we weworked with companies before
that are in the agriculturespace, but it seems like
innovation is slow to uptickthere. Because it's such a old
(21:41):
legacy market. Do you think thisis kind of helping infuse a bit
of innovation to their?
Ido Margalit (21:47):
Well, at least in my company? Yes. Yes. We
wouldn't have existed. So as faras my own personal perspective,
that is correct. Maybe also,there's a lot of shift is, you
know, to indoor, verticalgrowing vegetables. And I
believe that a lot of thesolutions that were developed in
the past five, six years can Ibe to actually utilize in that.
(22:08):
So as far as a those innovationsin cannabis, then yes, I believe
that actually can be should takemuch more from the agriculture
industry, rather than than theagriculture industry taking from
cannabis. But you will haveeventually some sort of a
synergy.
Ronjini Joshua (22:22):
Yeah, yeah, absolutely. So what do you guys
see as far as like, kind of yournext five to 10 years,
obviously, coming into the USmarket at some point, but for
cannabis, and not just him? Butwhat do you see is like kind of
the big industry trends that aregoing to be happening? Wow,
Ido Margalit (22:41):
I have to say, and as honestly as possible, I
catered the growers, I don't settrends of God, or we want these
types of flowers, we want thattype of collaborator, I don't
set the trends, I just bring thesolution for the growers that
fit the trends of the market. SoI don't assume to have any, any
forecasting are where they'regoing. What I can tell you is
(23:03):
that at least with us, whateverthe market is going, we're going
to bring the standardization anduniformity that it needs.
Ronjini Joshua (23:10):
Yeah, and the research, and the research and
the research and science. Well,this is awesome. Anything we
didn't get to talk about, thatyou are excited about.
Ido Margalit (23:20):
I think we covered we
Ronjini Joshua (23:21):
covered a lot.
Yeah, we covered a lot. Well,thank you so much, everyone.
Yeah, please, please.
Ben Michaels (23:26):
Um, so I'm really curious. Because like, I know,
like, Colorado specifically hasrecently changed the way that
they go, you know, seed, youknow, to flower, and tracking
that between medical andrecreational. And since, you
know, you're kind of approachingit of like, you know, the entire
US, right, like any legal state,do you have you found anything
(23:46):
so far of like, you know, aremore medical people, you know,
wanting your help, or, or more,you know, recreational people?
Or they, cuz I think everystate's like a little different
between now they have the trackthat you know, so have you ran
into any issues with, you know,trying to keep that legal and
good.
Ido Margalit (24:03):
I received already in the conference, some
questions like that, and as Iindicated, we're not medical
recreational in the UnitedStates. So we're not actually
faced with it doesn't apply forhim. He does apply. He's they're
Ronjini Joshua (24:13):
taking the smarter approach. They're
waiting till all this stuff hasbeen Yes, you know, cemented,
Ido Margalit (24:19):
but they have a very good reply. Technically, we
have the solution, because wehave genetic markers. The way
that enabled us to actuallybring the stable cannabis is
that we invested a lot of moneyin genetic markers. Oh, and with
those genetic markers, you canwe can actually track our
genetics. So if you buy buy seedfrom us, let's say that we are
already in the medical orrecreational market in here in
(24:40):
the US, you buy the sea from us,you propagate the plant, you get
the flower, I can test theflower, see the genetics using
my genetic markers and economicit's mine are not mine. So the
technical solution we alreadyhave it do a uplights not not
currently,
Ben Michaels (24:56):
yet. Not yet. Not yet. Yeah, TBD. Yes. cuz
Ronjini Joshua (25:01):
I said, Well, you know, it's been fantastic
talking to you. I hope you havean awesome show and hopefully we
can see you guys in the cannabismarket very soon. You will.
Yeah. And hear more about CRISPRalso.
Ido Margalit (25:15):
Yes, very exciting. Thanks. Thank you for
having me. Thank
Ronjini Joshua (25:18):
you. Thank you.
The Green Room podcast isbrought to life by green seed
PR, cannabis green tech focus PRagency, and a dedicated
production team of editorsmixers and show Booker's. A huge
thank you to the vessel team forproviding their studio for our
recording. Don't forget tosubscribe and share the
greenroom podcast with friends,colleagues, and family. That way
(25:39):
you'll never miss an episode andwe can keep the lights on. If
you're feeling extra generous.
Please leave us a review on yourfavorite podcast listening
platform. You can also find uson Instagram at Green DPR and
did live video versions of allof our podcasts on YouTube.
Would you like to be on theguests on the show? Or do you
have a great guest referral?
Awesome. Submit your guests atGreen CPR comm slash the hyphen
(26:02):
green hyphen room. Thanks forlistening and be well
Hi, this is Ronjini Joshua, I'm the host of
the green room podcast. Thislast week we were at mjbizcon.
And we met some amazing guestsand heard about some really cool
brands that are innovating thecannabis industry and and what's
coming next in the new year.
Hello, today we're here with IdoMargalit, the CEO of can breed.
Thank you for joining us on thepodcast. Thank you.
Ido Margalit (00:35):
Glad to be here.
Ronjini Joshua (00:36):
Yeah. And so we're here for mjbizcon. This
week, and what is the mostexciting thing to you about
what's going on this week?
Ido Margalit (00:44):
Well, I would say that this is the first
conference in cannabis thatwe're participating in
specifically also in the UnitedStates. Okay. I think the most
amazing thing is the sheer sizeof this conference, the amount
of people I mean, coming fromIsrael and also seeing the
European operations This isdoesn't come anywhere close to
that.
Ronjini Joshua (01:03):
Yes. Is this your first time you're, you're
exhibiting this year we areexpanding? And is this your
first time at mjbizcon? Or asyour first time exhibiting both
both? Okay. Okay. Okay, cool. SoI would love to hear a little
bit more about yourself and yourbusiness and can breed and what
you guys are doing at the showwhat you expect out of it and
some exciting things that youexpect to come out of cannabis
(01:26):
in 2022.
Ido Margalit (01:28):
Yeah, I'd be very happy to tell you everything.
Yeah. So maybe a little bitabout myself, please. So I'm an
agronomic by my education andalso have a master's in
business. I have 23 years ofexperience in Israeli life
sciences sector, great workingfor pharmaceutical companies for
agricultural companies.
Actually, the previous positionthat I held before founding this
company was being the BusinessDevelopment Manager for
(01:51):
Syngenta. Syngenta is theEuropean Monsanto, okay? And at
their seeds division, whichwould lead to the reason why we
founded Cambria. Okay. And aboutfive years ago, both me and also
the other co founder Dr. TangChairman we he was a scientist
also at the seeds division inSyngenta, we decided that we
want to create our own seeds andgenetics company that uses these
(02:15):
really innovative andbreakthrough technology called
CRISPR. I don't know if youheard about this technology. It
just won by the way, the 2020chemistry Nobel Prize, oh wow,
this is gonna revolutionizemedicine, agriculture as we know
it. So we're already eight yearsago, we became a acknowledge
with this technology. And wesaid, Okay, we're going to form
our own genetics and seeds,company, and we wanted to do new
(02:37):
things and develop betteragricultural crops. But there
was no money. Nobody understoodCRISPR means here, after almost
a decade after developing it,few people know about this
technology. So investors knewnothing. And it was that we want
to do CRISPR on tomatoes. And soI said, well, so that
interesting, there was no money.
(02:58):
And then we looked at cannabis.
Now immediately, as seeds,industry people, we understood
the two biggest gaps that existin cannabis. And we said there,
we can solve it. And the twobiggest gaps is one, it's very
expensive to grow, because thegenetics do not fit mass scale
production. And the otherproblem is there's no
standardization, there's nouniformity and consistency. So
the two solutions are stableseeds and enhancing those seeds
(03:20):
with agronomic traits that willenable very efficient and and
very high quality material.
Ronjini Joshua (03:30):
Yeah, so I think what I'm hearing a lot this
year, and just seeing mjbizconis a lot of people are focusing
on the seeds, because that'skind of the future of cannabis
is how are we going to scale theproduction of cannabis? And how
are you going to get the sameplants in different places? And
and and all that. So how is thatincorporated into your business?
(03:52):
And, you know, what are youlooking at as the trends of what
you're doing with CRISPR.
Ido Margalit (03:57):
So I think the biggest solution and the most
game changing solution isactually bringing those seats
when you do not need to do anymore cloning, no more clones,
once you have the stable seats,no more tissue culture cloning,
no more mother vegetative fromother plants, cloning, normal
cloning, you buy a bag of seeds,10,000 seeds, 100,000 seeds, 1
million seeds, and you put allof them in the in the greenhouse
(04:20):
and you get the identicalplants. So it saves time, it
saves labor. And after that youget the consistency and the
uniformity. This is the biggestbiggest solution. But as I said,
it's not enough because stillthere's a lot of problems. I
mean agricultural crop, you havea lot of hardships, you have
Diseases Attacking it, you haveto adapt the structure of the
cannabis plant mean, the soy andthe tomatoes we consume today.
(04:42):
We're actually domesticated fordecades, if not for centuries to
fit, intensive agricultureoutputs and halibuts was not so
only using CRISPR. Can youactually domesticate the
cannabis plant and fit it intointensive agricultural farms
within a very short time? Wedon't have the two three decades
wait for conventional breedingto get to that we need to do
(05:04):
that within the next five years,and only CRISPR can do that
solution. Wow.
Ronjini Joshua (05:09):
So what do you see as the biggest opportunity
with that then, obviously, massscale production, but coming
from Israel and coming into theUS market, how are you guys kind
of working through thechallenges of the US market.
Ido Margalit (05:24):
So I think that we sold one big challenge very
easily because we are both inthe hemp and also in the, in the
medical and recreationalsegment. So the medical
recreational segment, we soldthe situation in the US very
simple. We're not in there.
Until you solve it federally,we're not touching any kind of
base in the in the medical andrecreational so that we're only
(05:45):
focused on the hemp side in theUnited States. And I think that
as I said, we should we bringthis uniform seats when you buy
1 million seeds from us is goingto be identical consistency and
standardization. But then thegrowth here face a lot of other
problems they face also the highTHC. So with crisper, you can
have no THC, THC free plants.
(06:05):
There's another downside togrowing hemp because it's an
outdoor production mainly, atleast if you want to have your
production costs go really down,you can't do it in the
greenhouse, then you have aweeds that the take over the
growth and they you have 10 to15% loss of duty weeds. So we
have a herbicide resistant hemp,and also disease resistant, etc,
(06:26):
etc, we have these economicaltrade platform that solves
basically, I would say most ofthe challenges of growing hemp
in the United States. So you cando effectively with high
quality.
Ronjini Joshua (06:36):
So tell us a little bit about your team
because it sounds like you havea very scientific focus team. So
tell us a little bit about howit what you guys are doing as
far as the research and thedevelopment within the company.
Ido Margalit (06:48):
I would say that we are much more a biotech
company, an agriculture company.
So we have over 20 Scientistsworking at the company. Most of
them are molecular biologists.
It's a fancy name forgeneticists. So what we
basically do we look at thedifferent challenges that the
growers face, we'll look at thetraits that will solve those
(07:09):
different challenges. Ourscientists look at the genes
that once you edit them, you getthose traits and then we design
the CRISPR that will actuallyedit the gene to get the
positive trade out of theplants. So this is what we do.
So we are basically a geneticbiotech company that's focused
mainly in cannabis at this pointof time. By the way, we're not
only doing cannabis, but westarted cannabis. We're focused
(07:31):
on cannabis. We're doing manyother crops as well.
Ronjini Joshua (07:34):
Okay, so your group crop scientists, yeah. All
crops. Okay. Land scientists,plant scientists, though. Okay.
Well, but so what you do withCRISPR can apply to any kind of
plant or agriculture.
Ido Margalit (07:45):
It does. And it's exactly what we do. We're also
in soy, we're also in tomatoes,where most of the cash crops for
agriculture, but we began incannabis, our journey as I said,
our journey actually begancannabis because there was money
in cannabis. Right. But now,everybody well, at least in my
in my segment, now people knowthat CRISPR and people
(08:05):
acknowledge the fact that allagricultural crops need to be
enhanced, and only CRISPR willbring the solution for the for
the for the future ofagriculture, and feed the world.
So now it's much easier for usto get the money to do other
crops as well.
Ronjini Joshua (08:18):
What kind of companies do you guys partner
with? Well, we
Ido Margalit (08:22):
partner both with multinational seeds, companies,
we partner also with a couple ofcannabis companies. And of
course, we partner with a lot ofresearch institutes. But but as
I said, since we're not onlycannabis when we partner with
those guys, it's not just forcannabis. It's for a lot of
other things. But we are lookingvery actively to partner with
young plant nurseries, seedlingnurseries, and also for
(08:44):
cannabis. Because we see theevolution of the cannabis
industry. So you have the plantand the seeds business. The next
in the in the supply chain areactually the nurseries. Yeah,
because in agriculture, thefarmers, let's say vegetables,
which is a high value croproaming greenhouses, just like
canavese the farmers they don'tbuy the seeds from the seed
(09:05):
companies they buy young plantplanners. Yeah, actually our
customers are not growsthemselves. They are the plant
nurseries. So we've come here toactually look for customers
because we're starting to sellin 2022. So we're talking to the
farmers and to the growers,because they're much more than
that than they are in nurseries,but we're also looking for the
(09:26):
nursery.
Ronjini Joshua (09:26):
Do you imagine that you know in the future when
it is legal here in the UnitedStates and wherever else it's
going to be legal. Do youimagine there'll be cannabis
nurseries
Ido Margalit (09:35):
of course yeah, in Israel, there's already starting
to be a young plant nurseriesfor cannabis. Okay, there's very
few in the United States andit's very few in Canada, but at
least I can tell you what theytold us in Israel. So there's
young plant nurseries that arenot doing cannabis, but they
have the know how and theresources to add cannabis and
they said, We're waiting forstable seats. There's no reason
for us to do any germination ofseason to end to sell young
(09:58):
planetaries if there's no stableseats, Now you've come now we
are entering also the cannabisindustry.
Ronjini Joshua (10:03):
So that is a challenge I've heard of and
don't obvious I'm not a farmeror grower. So I don't know much
about it. But is that a bigissue for the cannabis industry
where they're, you know, growingcertain plants, but not all of
them are producing what theyneed? Is it? What is the what is
the loss amount when you do acrop? Typically,
Ido Margalit (10:25):
what exactly do you mean from the amount of the
cannabinoids,
Ronjini Joshua (10:28):
you mentioned it? Yeah, you were mentioning
that like, you know, thegermination doesn't kind of
fully, fully mature. So do allthe seeds because the seeds are
not the same? Or because they'renot uniform? Are you seeing a
lot of drop off of plants thatthey can't people can't use?
Ido Margalit (10:46):
Well, in our products or from the other
products in the industry. So Ithink we met already potential
clients in the in the days thatwe've come before the
conference. And they said, Youguys have a lot of challenges.
You don't need to market educatethe people that you must need
seeds to replace cloning, you'reactually challenge is all the
previous companies that came andsaid that they're doing exactly
(11:08):
what you're doing. And theydidn't have it. So they had low
germination rates, they do nothave the consistency, the
stability and the uniformity. Sothe challenge is that proving
that we're not doing the same BSas the other guys before us.
That is the biggest challenge.
And we're not basing we actuallyhave 1%, stable genetics, we're
actually bringing the practicesof the conventional seeds
business. This is the first timewe've broken all the glass
(11:29):
ceilings that in the pastdecades existed in this
industry. And I hope that ourpotential customers will trust
us and understand that we're notdoing the BS that the guys
before us have done.
Ronjini Joshua (11:45):
So you guys are coming from Israel. Can you tell
me a little bit more about yourlike kind of how you guys got
started? How did cambrie getstarted in the first place?
Ido Margalit (11:52):
So as I mentioned, a US being for the seeds
industry. And it was very easyfor us to actually understand
those gaps. Okay, so weimmediately understood any
agricultural crop, and cannabisis just another crop crop. By
default, you have to grow itfrom seed doing a propagation
from vegetative propagation. Youonly do that if the plant does
(12:13):
not know how to propagate itselffrom seeds. So bananas,
strawberries, even potatoesuntil recently, you did
vegetative cloning, vegetativereproduction of it. And can I
be, well, everybody knows theseeds, it doesn't have to
produce itself. But it's notenough just to use the seed as
nature has done it because it'snot stable. When you take a seat
(12:33):
for one plant or the day you get100 seeds for one plant, all
those 100 seeds are geneticallydifferent from each other. You
need to invest a lot of science.
That's why we're we're alreadyalmost five years existing. And
people have asked me already inthe conference today. So what is
your revenue? And I say, I mightsay even one very proudly, one
big fat zero, because five yearshuge amounts of investment. This
(12:55):
is science. It takes a longtime. And if people believe Oh
yeah, I'm gonna do the same, youknow, within two or three
cycles, six to eight months aregoing to have the same thing as
you had, and I'm going to sellit. No, it takes five years to
get to the point that we arethat is why we actually do have
the stable genetics. Yeah. Andthis is the route that we did.
We come from the conventionalseeds business, we're taking the
(13:18):
practices, and for the firsttime we're inputting them into
cannabis, and I think is thefirst stepping stone of the
cannabis industry to mature andbecome a standard diseased
industry.
Ronjini Joshua (13:30):
Yeah, and that's another problem that, you know,
another problem people arefacing is standardization and,
and getting quality productsthat are streamlined, you know,
I think this kind of seedgenetics probably really helps
mass produce this at a scalablekind of rate.
Ido Margalit (13:46):
Exactly. Yeah.
That is a joke in Hebrew that Ican translate, I believe to
English, but it's like this, thecannabis industry over the world
is like building a penthouse ona high rise building, but
building it from the top down,right, okay. And there's no
foundation and the foundationthis business is genetics. So if
there's no stable genetics, youwill never have this
standardization, you will neverbe able to go and buy at the
(14:06):
store the same time you receiveda very good vibe, a very good
feeling. You enjoy the productand you go again, I mean, when I
buy a Coke, I expect my coke inIsrael in the US in England,
wherever to be the same. Youcan't get that and Canalis only
when you get to the stablegenetics like we have will you
get to that point for bothrecreational and of course
medical, you will get the sametype of reproducibility and
(14:27):
standardization.
Ben Michaels (14:30):
Have you found that you've been able to you
know, because like there's thestrands that are very popular
and across the board and thenthere's like more of the
boutique brands that are reallytrying to get complex you know,
terpenes and high THC when youare these seeds you know that
you're making right now are youtrying to accomplish all of that
you're trying to get high THCand complex terpenes with with
(14:53):
that stability, are you findingthat you have to sacrifice one
or the other for thatconsistency.
Ido Margalit (14:59):
We can look cover the entire spectrum of the
market, it's impossible, as ourstrategy is to have a few dozen
varieties that we select Appleaccording to two criteria. I
mean, you have people heregrowing the same variety in the
winter, in the summer in theautumn growing in Washington
growing in California, itdoesn't matter that agricultural
crops, you have to have aspecific variety for specific
(15:20):
season in a specific spot. Soalready by default, we
understand that using just onevariety, it doesn't fit. It
doesn't
Ronjini Joshua (15:27):
work like that, like fruits and vegetables.
They're exactly there duringcertain times of the year.
Exactly.
Ido Margalit (15:31):
So we we are, we're going to have a product
profile of a few dozen varietiesthat are going to be selected
according to plant performance.
This grows well in the winter,this grows well in the summer,
okay. And from those that fitthe summer, winter, wherever
indoor outdoor that we have alsoselection according to the
contaminant concentration, thisis high THC, low CBD high CBD
(15:51):
this is even, et cetera, etcetera. So we will have a
catalog that hopefully coversthis spectrum, will it fit?
Specifically I want thisspecific Can I get a
cannabinoid? Nothing CBD or THC,whatever, or this specific
terpene? Maybe not. But if youwant the uniformity and the
standardization, and you'rewilling to let go of that
specific teeny, weeny littlething, then I'm your guy.
Ronjini Joshua (16:16):
Yeah, I think I think maybe not so much for the
boutiques, but for the MSOs thatare going to be doing national
production of big, big brandsthat are going to be doing that
they're going to be looking for,you know, your kind of solution.
But there's, that's, that's kindof how the market is today,
right? You've got boutiquepeople like let's, you know,
we've been talking a lot aboutthe comparisons between wine and
beer, and you've got the craftwine, and then you've got or the
(16:39):
craft beer, and then you've gotlike the large, you know, mass
produced, like big brands thatpeople like. So I think that
kind of translates
Ido Margalit (16:49):
complete with you.
And I like always to bring ametaphor from the conventional
agriculture business. Yeah. Sofrom our business, we have the
organics guys, right, right.
It's a niche market. So they'reabout three to 4%, the total
market so they won't buy theconventional seeds. They want to
own organic seeds from their ownorganic varieties. So they won't
go to the Monsanto to thepioneers of those large,
(17:11):
multinational companies. So Icater the 95 96% of the market.
So the four or 5% niche to take.
So probably I can give asolution to them. Maybe they
wanted to invest and to pay meto develop their genetics, they
will be fit for growing fromstable seeds. Maybe that's
assumption solution. But I aimfor the 95% of the market, right
(17:31):
for the nation, boutique market.
Ronjini Joshua (17:34):
Yeah. Well, I mean, there has to be a little
bit of everything, right? No,absolutely. There will be. Yeah,
a little bit of everythingavailable. That's exciting. I
mean, it's really interesting tosee it be the industry be at the
stage and time and we're meetinga lot of people that are really
just getting into the groundfloor of what's happening with
cannabis and how it's going tobe blowing up in the next few
(17:58):
years. As, especially here as itbecomes legalized, it's going to
be kind of like a, it's going tobe something to look at, you
know, something to watch andsee. What are you most excited
about? I mean, you have a lot ofreally cool technology behind
what you're doing. What are youmost excited about?
Ido Margalit (18:14):
I would say I'm most excited about being the
groundbreaking company. Yeah, Ihave to say that. I mean, that
we've faced so many backlashesof the past five years, people
have been telling us and I stillreceive emails for massive
growth in the United Statessaying that you cannot get to
stable seats. you'rebullshitting and this is
something possible. This is soI'm so I'm breaking as I said,
(18:37):
glass ceilings, I'm changingconcepts. And also being the
first company to actually takingthis CRISPR technology and being
able to apply it in cannabiswhere so many other people have
failed. You have these largegrowers, a companies in Canada,
they failed, you know, thecanopy that Tiller that they
failed, and me as a smallIsraeli company, like like a
(18:59):
small commander unit, withlimited resources of limited
people were actually managed tosolve all those problems that
bigger, stronger and moreveteran people in in the
cannabis industry than us theycouldn't solve it. This is what
I'm really most excited about.
Ben Michaels (19:16):
So not to take a step back from what you were
excited about, but I find itvery interesting that you're
mainly the big focus right nowis the hemp and hemp market. So
I'm just curious so like it'ssome of the things like trying
to get you know, no THC with themost amount of CBD or literally
(19:37):
strengthening you know, the cellwalls of the plant, you know, so
it's, you know, whatever thathemp depending on what that hemp
is going to be used for. Do youhave some of that same variety
with you know, him specificCRISPR technology.
Ido Margalit (19:50):
So this is exactly what we're doing. And by the
way, using this gene editingthis CRISPR technology, I would
say the sky's the limit in inregard to what you can do to the
canavese planet hemp plantwellness exam is probably for me
hemp is also cannabis, ofcourse, it's the sky's the limit
that anything is possible fromplaying with all the different
cannabinoids from, as you said,changing the plant architecture,
(20:11):
I can tell you that one of theof the traits that we're working
on, not only does it make theplant autoflowering and by the
way autoflowering, we're notusing a ruderalis, you can play
with a gene that actually turnsoff and on the plant need to
look at the amount of daylightso you don't get the genetic
drift or with violence or thecrapping and people cross
(20:32):
Hamburg valleys, you get a lotof crap from from ruderalis in
this instance, you take the hempplant itself and you edit the
gene, there's no anything thatcomes from the root of it. So
you get a very good, very strongvery vigorous hemp plant. And
not only that this specific genealso makes the flowers appear
almost simultaneously. Soinstead of having you can say
like floors, then all theflowers more or less appeared
(20:53):
some fancy which makes it muchmore fitting for mechanical
harvesting. Oh
Ben Michaels (20:57):
wow.
Ido Margalit (20:58):
So you reduce the time you make the flowers appear
simultaneously and you can thenmechanically harvested like in
cotton like in soy like in allthe other our culture open field
crops.
Ben Michaels (21:08):
Yeah, no, that's such a such a pain and
especially for the ones that doit by hand and having everybody
do it because it's, you know,the the flowers growing
everywhere in differentdirections. There's no way to
streamline it. That'sincredible.
Ronjini Joshua (21:18):
Yeah. Do you think that, um, you know, this
kind of cannabis revolution? Doyou think it's opening up
opportunities for agriculturalinnovation, just in general that
like, cuz I, I mean, we weworked with companies before
that are in the agriculturespace, but it seems like
innovation is slow to uptickthere. Because it's such a old
(21:41):
legacy market. Do you think thisis kind of helping infuse a bit
of innovation to their?
Ido Margalit (21:47):
Well, at least in my company? Yes. Yes. We
wouldn't have existed. So as faras my own personal perspective,
that is correct. Maybe also,there's a lot of shift is, you
know, to indoor, verticalgrowing vegetables. And I
believe that a lot of thesolutions that were developed in
the past five, six years can Ibe to actually utilize in that.
(22:08):
So as far as a those innovationsin cannabis, then yes, I believe
that actually can be should takemuch more from the agriculture
industry, rather than than theagriculture industry taking from
cannabis. But you will haveeventually some sort of a
synergy.
Ronjini Joshua (22:22):
Yeah, yeah, absolutely. So what do you guys
see as far as like, kind of yournext five to 10 years,
obviously, coming into the USmarket at some point, but for
cannabis, and not just him? Butwhat do you see is like kind of
the big industry trends that aregoing to be happening? Wow,
Ido Margalit (22:41):
I have to say, and as honestly as possible, I
catered the growers, I don't settrends of God, or we want these
types of flowers, we want thattype of collaborator, I don't
set the trends, I just bring thesolution for the growers that
fit the trends of the market. SoI don't assume to have any, any
forecasting are where they'regoing. What I can tell you is
(23:03):
that at least with us, whateverthe market is going, we're going
to bring the standardization anduniformity that it needs.
Ronjini Joshua (23:10):
Yeah, and the research, and the research and
the research and science. Well,this is awesome. Anything we
didn't get to talk about, thatyou are excited about.
Ido Margalit (23:20):
I think we covered we
Ronjini Joshua (23:21):
covered a lot.
Yeah, we covered a lot. Well,thank you so much, everyone.
Yeah, please, please.
Ben Michaels (23:26):
Um, so I'm really curious. Because like, I know,
like, Colorado specifically hasrecently changed the way that
they go, you know, seed, youknow, to flower, and tracking
that between medical andrecreational. And since, you
know, you're kind of approachingit of like, you know, the entire
US, right, like any legal state,do you have you found anything
(23:46):
so far of like, you know, aremore medical people, you know,
wanting your help, or, or more,you know, recreational people?
Or they, cuz I think everystate's like a little different
between now they have the trackthat you know, so have you ran
into any issues with, you know,trying to keep that legal and
good.
Ido Margalit (24:03):
I received already in the conference, some
questions like that, and as Iindicated, we're not medical
recreational in the UnitedStates. So we're not actually
faced with it doesn't apply forhim. He does apply. He's they're
Ronjini Joshua (24:13):
taking the smarter approach. They're
waiting till all this stuff hasbeen Yes, you know, cemented,
Ido Margalit (24:19):
but they have a very good reply. Technically, we
have the solution, because wehave genetic markers. The way
that enabled us to actuallybring the stable cannabis is
that we invested a lot of moneyin genetic markers. Oh, and with
those genetic markers, you canwe can actually track our
genetics. So if you buy buy seedfrom us, let's say that we are
already in the medical orrecreational market in here in
(24:40):
the US, you buy the sea from us,you propagate the plant, you get
the flower, I can test theflower, see the genetics using
my genetic markers and economicit's mine are not mine. So the
technical solution we alreadyhave it do a uplights not not
currently,
Ben Michaels (24:56):
yet. Not yet. Not yet. Yeah, TBD. Yes. cuz
Ronjini Joshua (25:01):
I said, Well, you know, it's been fantastic
talking to you. I hope you havean awesome show and hopefully we
can see you guys in the cannabismarket very soon. You will.
Yeah. And hear more about CRISPRalso.
Ido Margalit (25:15):
Yes, very exciting. Thanks. Thank you for
having me. Thank
Ronjini Joshua (25:18):
you. Thank you.
The Green Room podcast isbrought to life by green seed
PR, cannabis green tech focus PRagency, and a dedicated
production team of editorsmixers and show Booker's. A huge
thank you to the vessel team forproviding their studio for our
recording. Don't forget tosubscribe and share the
greenroom podcast with friends,colleagues, and family. That way
(25:39):
you'll never miss an episode andwe can keep the lights on. If
you're feeling extra generous.
Please leave us a review on yourfavorite podcast listening
platform. You can also find uson Instagram at Green DPR and
did live video versions of allof our podcasts on YouTube.
Would you like to be on theguests on the show? Or do you
have a great guest referral?
Awesome. Submit your guests atGreen CPR comm slash the hyphen
(26:02):
green hyphen room. Thanks forlistening and be well
Popular Podcasts
Bookmarked by Reese's Book Club
Welcome to Bookmarked by Reese’s Book Club — the podcast where great stories, bold women, and irresistible conversations collide! Hosted by award-winning journalist Danielle Robay, each week new episodes balance thoughtful literary insight with the fervor of buzzy book trends, pop culture and more. Bookmarked brings together celebrities, tastemakers, influencers and authors from Reese's Book Club and beyond to share stories that transcend the page. Pull up a chair. You’re not just listening — you’re part of the conversation.
On Purpose with Jay Shetty
I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com